GPR35 inhibitor (ThirtyFiveBio)

N/A

Report date: 2025/06/11 10:41:30
NME

Base Information

Drug NameGPR35 inhibitor (ThirtyFiveBio)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionG-protein coupled receptor 35 inhibitors
TargetsG-protein coupled receptor 35
Therapy Area/IndicationsColitis, UlcerativeGastrointestinal DiseasesGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThirtyFiveBio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesThirtyFiveBio Ltd
Inactive CompaniesN/A
Active IndicationsColitis, UlcerativeGastrointestinal DiseasesGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A